drugset / Trial / NCT00413153
Metabolic Effects of Switching Kaletra to Boosted Reyataz
RandomizedParallel-groupOpen-labelTreatment
Summary
To study the effects of switching from Kaletra to Boosted Reyataz on glucose, lipids and fat in HIV-infected patients.
Timeline
- Start
- 2006-05
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 300 mg | — |
| Comparator | Lopinavir | Other / unclassified | — | — |
| Comparator | Ritonavir | Other / unclassified | 100 mg | — |
| Comparator | Ritonavir | Other / unclassified | — | — |